Quest Diagnostics Increases Share Repurchase Authority by $750 Million
News Jan 26, 2011
During 2010, the company repurchased approximately 15 million shares of common stock for $750 million. The company had 171 million shares outstanding as of December 31, 2010.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
International Conference on Hepatology and Liver Diseases
Jun 10 - Jun 11, 2019